首页> 外文期刊>Pharmacology and Toxicology: An International Journal >Effects of polyamine synthesis inhibition on polyamines, growth and mechanical properties in hypertrophic rat urinary bladder.
【24h】

Effects of polyamine synthesis inhibition on polyamines, growth and mechanical properties in hypertrophic rat urinary bladder.

机译:多胺合成抑制对肥厚性大鼠膀胱中多胺,生长和机械性能的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The polyamines putrescine, spermidine and spermine, are ubiquitous intracellular metabolites associated with growth and protein synthesis. In this study effects of polyamine synthesis inhibition on bladder growth, polyamine levels and mechanical properties were investigated in rat urinary bladder subjected to partial outflow obstruction that causes bladder hypertrophy. The S-adenosyl methionine decarboxylase inhibitor CGP-48664 (5 and 20 mg kg-1) was administered alone or in combination with the ornithine decarboxylase inhibitor DFMO (500 mg kg-1), starting one day before creation of partial outflow obstruction and then daily for 7 days. The bladder muscle level of putrescine was increased 38 times and that of spermine reduced by 4 times while spermidine was unchanged after treatment with CGP-48664 (20 mg kg-1). The increase in putrescine was abolished in animals receiving CGP-48664 in combination with DFMO. Treatment with polyamine synthesis inhibitors could not prevent or reduce the hypertrophy of the bladder as judged by bladder wet weight and protein contents. The effects on polyamine quantities were not associated with changes in Ca(2+)-force relationship or in agonist and electrically stimulated force. In summary, treatment of rats with polyamine synthesis inhibitors resulted in changes in polyamine levels in the growing urinary bladder but did not affect growth or mechanical properties.
机译:多胺腐胺,亚精胺和精胺是与生长和蛋白质合成相关的普遍存在的细胞内代谢产物。在这项研究中,研究了多胺合成抑制对膀胱生长,多胺水平和机械性能的影响,该膀胱在受到部分流出阻塞而引起膀胱肥大的大鼠膀胱中。 S-腺苷甲硫氨酸脱羧酶抑制剂CGP-48664(5和20 mg kg-1)单独给药或与鸟氨酸脱羧酶抑制剂DFMO(500 mg kg-1)结合使用,从产生部分流出阻塞的前一天开始,然后每天7天。用CGP-48664(20 mg kg-1)处理后,腐胺的膀胱肌水平增加了38倍,精胺的膀胱肌水平降低了4倍,而亚精胺则保持不变。接受CGP-48664与DFMO联合治疗的动物中,腐胺的增加被消除。由膀胱湿重和蛋白质含量判断,用多胺合成抑制剂治疗不能预防或减少膀胱肥大。对多胺量的影响与Ca(2+)力关系或激动剂和电刺激力的变化无关。总之,用多胺合成抑制剂对大鼠进行治疗可导致生长中的膀胱中多胺水平发生变化,但不会影响其生长或机械性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号